ClinicalTrials.gg
Not yet recruitingNCT07050784Updated Jul 8, 2025

Wearable Garment vs Gel Electrodes for Electrical Muscle Stimulation

An interventional study of Hydrogel electrodes and Dry polymer-textile electrodes with Skin Lotion A in Healthy, sponsored by Myant Medical Corp.. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by Myant Medical Corp. · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to evaluate whether textile-based electrodes can provide neurostimulation that is comparable in comfort and effectiveness to traditional hydrogel electrodes in healthy adults.

The main questions it aims to answer are:

  1. Is the perceived sensation of stimulation using textile electrodes non-inferior to that of hydrogel electrodes?
  2. Is the current required to evoke muscle contractions similar between textile and hydrogel electrodes?

Each participant will complete three stimulation conditions in random order across separate visits:

  1. hydrogel electrodes (standard),
  2. dry polymer-textile electrodes with lotion, and
  3. dry textile electrodes with hydrogel pads

Electrical stimulation will be delivered to the lower leg muscles using a wearable sleeve with integrated electrodes. The investigators will assess sensorimotor thresholds (e.g., detection, motor, and full motor threshold), skin-electrode impedance, and torque. Participants will also rate stimulation comfort, intensity, and sensation location via questionnaire.

After the three primary arms, participants may optionally complete two additional arms using different moisturizers applied to the textile electrodes to evaluate their impact on stimulation performance.

The results of this study will help determine whether textile electrodes can be used as an effective and comfortable alternative to hydrogel electrodes in wearable neurostimulation applications.

Read the detailed description

Neurostimulation involves the use of electric current delivered through skin-surface electrodes to activate muscles. It is commonly used for purposes such as muscle strengthening, motor function improvement, blood flow enhancement, and in neuroprostheses. Standard neurostimulation systems typically rely on disposable hydrogel electrodes, which can cause skin irritation and tend to dry out over time. These limitations make hydrogel electrodes less suitable for long-term or repeated use.

Textile-based electrodes are an emerging alternative. These electrodes are integrated into wearable garments, making them washable, reusable, and more comfortable for extended wear times. However, research directly comparing their effectiveness and user experience compared to hydrogel electrodes is limited.

The goal of this study is to compare textile electrodes to gold-standard hydrogel electrodes for muscle activation and perceived stimulation sensation. The investigators hypothesize that: 1) there will be no clinically meaningful difference in participants' perception of the stimulation between textile and hydrogel electrodes, and 2) there will be no significant difference in the stimulation current required to elicit functional contractions.

This is a crossover randomized controlled trial involving three primary arms: 1) hydrogel electrodes, 2) dry polymer-textile electrodes with lotion, and 3) dry textile electrodes with gel pads applied. Each participant will perform all three arms in a randomized order with at least 24 hours between visits. Stimulation will be delivered to the calf and tibialis anterior muscles using the same electrical stimulator and settings in all conditions. Following completion of the three primary arms, participants will be given the option to complete an additional two arms using different types of commercially available moisturizers on the dry textile electrodes to assess comparative on-body performance of different water-based moisturizers. All moisturizers are commercially available and are labelled Skin Lotion A, B, and C in the 'Arms and Interventions' section.

A sample size of 18 participants is required to detect a Cohen's f of 0.40 with 95% power and a significance level of ⍺ = 0.05 for a within-subjects one-way repeated measures analysis of variance (ANOVA) with three conditions. To preserve statistical power, the investigators will recruit 20 participants. Pilot data comparing textile to hydrogel electrodes provided an estimated effect size of f = 0.65. Given the pilot data was not randomized, which likely inflated the observed effect size, the investigators conservatively based their sample size calculation on a Cohen's f of 0.40 (i.e., a large effect size) to ensure adequate power to detect a potentially smaller true effect.

A non-inferiority analysis will compare perceived stimulation intensity on a 10-point numerical rating scale. A 2-point difference is set as the non-inferiority margin based on prior research on the minimal clinically important difference. Textile electrodes will be considered non-inferior if the upper bound of the 95% confidence interval for the difference in intensity remains below this threshold. Repeated measures ANOVAs and Tukey's post hoc tests will be used to analyze the outcome variables where appropriate.

02

Conditions studied

  • Healthy

Keywords

  • Textile electrodes
  • Smart clothing
  • Neuromuscular electrical stimulation
  • Transcutaneous electrical nerve stimulation
  • Functional electrical stimulation
03

In context

Lead sponsor

Myant Medical Corp. is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy (without a known diagnosis of cardiovascular, pulmonary or neurological condition)

Exclusion criteria

Exclusion Criteria:

  • Known pregnancy
  • Implanted defibrillator or pacemaker
  • Pain in the body part being tested
  • Open wound or dressing (e.g. band-aid) on a body part that needs to be in contact with the electrodes
  • Severe frailty such that donning or doffing the garment may cause a danger of falling
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Hydrogel electrodes

    Gold-standard comparator

    Device: Hydrogel electrodes

  • Experimental
    Dry polymer-textile electrodes with Skin Lotion A

    Device: Dry polymer-textile electrodes with Skin Lotion A

  • Experimental
    Dry textile electrodes with gel pads attached to the electrode

    Device: Dry textile electrodes with gel pads attached to the electrode

  • Experimental
    Dry polymer-textile electrodes with Skin Lotion B

    Device: Dry polymer-textile electrodes with Skin Lotion B

  • Experimental
    Dry polymer-textile electrodes with Skin Lotion C

    Device: Dry polymer-textile electrodes with Skin Lotion C

Interventions

  • DeviceHydrogel electrodes

    Neurostimulation using standard self-adhesive hydrogel electrodes

  • DeviceDry polymer-textile electrodes with Skin Lotion A

    Neurostimulation with dry polymer-textile electrodes using Skin Lotion A

  • DeviceDry textile electrodes with gel pads attached to the electrode

    Neurostimulation with dry textile electrodes with gel pads attached to the electrode

  • DeviceDry polymer-textile electrodes with Skin Lotion B

    Neurostimulation with dry polymer-textile electrodes with Skin Lotion B

  • DeviceDry polymer-textile electrodes with Skin Lotion C

    Neurostimulation with dry polymer-textile electrodes using Skin Lotion C

06

What researchers measure

Primary outcomes

  1. Perceived intensity of stimulation

    Participants will rate the perceived intensity of electrical stimulation at the current required to elicit 20% of their maximal voluntary contraction (MVC). Intensity will be assessed using a 10-point numerical scale, where 0 represents no sensation and 10 represents painful stimulation.

    Time frame: At each of the 5 study visits (Visit 1 through Visit 5) over approximately a 3-week period.

Secondary outcomes

  1. Sensorimotor responses to electrical stimulation

    Current amplitude required to elicit various sensorimotor responses will be recorded. Participants will receive electrical stimulation to the lower leg. The study will measure: * Detection threshold: the smallest current the participant can feel. * Motion threshold: the lowest current that causes visible movement. * Full range of motion amplitude: the current needed for full joint range of motion. * Just noticeable difference: the smallest change in current a participant can detect. Stimulation will be increased gradually and stopped if discomfort is reported. All stimulation will not exceed safe current limits (i.e., 100 mA).

    Time frame: At each of the 5 study visits (Visit 1 through Visit 5) over approximately a 3-week period.

  2. Kinematic recruitment curves

    Kinematic recruitment curves will be created by measuring ankle movement during stimulation. A camera will record the ankle as stimulation amplitude increases in small increments. Joint angles will be measured from the video and plotted against stimulation intensity to produce kinematic recruitment curves.

    Time frame: At each of the 5 study visits (Visit 1 through Visit 5) over approximately a 3-week period.

  3. Torque

    Maximum voluntary contraction (MVC) will be determined through three maximal effort contractions of the ankle. Electrical stimulation will then be applied to determine the current required to produce 20% of the MVC.

    Time frame: At each of the 5 study visits (Visit 1 through Visit 5) over approximately a 3-week period.

  4. Sensation questionnaire

    Participants will complete a questionnaire following stimulation to report: * How the stimulation felt * Where it was felt * How comfortable it was, rated on a 7-point scale, with 0 being comfortable and 7 being uncomfortable

    Time frame: At each of the 5 study visits (Visit 1 through Visit 5) over approximately a 3-week period.

  5. Skin-electrode impedance

    To measure electrical impedance, a small electrical signal will be sent through the electrodes across a range of frequencies, and resistance will be recorded. This helps evaluate how well the electrodes conduct current during use.

    Time frame: At each of the 5 study visits (Visit 1 through Visit 5) over approximately a 3-week period.

07

Study locations

1 site
  • Myant Medical Corp
    Mississauga, Ontario L5K 2L1, Canada
08

References and documents

Individual participant data

Plan to share: No — Study is internal

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2025; primary completion for Sep 2025, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2025
First posted
Jul 3, 2025
StartEst.
Jul 1, 2025
Primary completionEst.
Sep 2025
CompletionEst.
Sep 2025
Last update
Jul 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07050784
Lead sponsor
Myant Medical Corp.
Responsible party
Sponsor
First posted
Jul 3, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
Sep 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Jul 8, 2025

Study contacts

Amirali Toossi
Contact
amirali.toossi@myant.ca
4164237906
Milad Alizadeh Meghrazi
principal investigator · Myant Medical Corp.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion